E. A. Hoge, A. Ivkovic, and G. L. Fricchione, Generalized anxiety disorder: diagnosis and treatment, Brit. Med. J, vol.345, pp.37-42, 2012.

X. Zhang, Generalized anxiety in community-dwelling elderly: Prevalence and clinical characteristics, J. Affect. Disord, vol.172, pp.24-29, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02400630

K. Domschke and J. Deckert, Genetics of anxiety disorders -status quo and quo vadis, Curr. Pharm. Des, vol.18, pp.5691-5698, 2012.

C. E. Sartor, Common heritable contributions to low-risk trauma, high-risk trauma, posttraumatic stress disorder, and major depression, Arch. Gen. Psychiatry, vol.69, pp.293-299, 2012.

A. Tadic, Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression, Am. J. Med. Genet. B. Neuropsychiatr. Genet, vol.117, pp.1-6, 2003.

J. You, S. Hu, B. Chen, and H. Zhang, Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder, Psychiatr. Genet, vol.15, pp.7-11, 2005.

X. Zhang, Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (The ESPRIT study), Transl. Psychiatry, vol.5, p.536, 2015.

C. Faravelli, The role of life events and HPA axis in anxiety disorders: a review, Curr. Pharm. Des, vol.18, pp.5663-5674, 2012.

K. Hilbert, U. Lueken, and K. Beesdo-baum, Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review, J. Affect. Disord, vol.158, pp.114-126, 2014.

G. Gerra, Neuroendocrine responses to psychological stress in adolescents with anxiety disorder, Neuropsychobiology, vol.42, pp.82-92, 2000.

H. Dohlman, J. Thorner, M. Caron, and R. Lefkowitz, Model systems for the study of seven-transmembrane-segment receptors, Annu. Rev. Biochem, vol.60, pp.653-688, 1991.

S. D. Hood, Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge, J. Psychopharmacol, vol.25, pp.78-86, 2011.

M. U. Shad, A. M. Suris, and C. S. North, Novel combination strategy to optimize treatment for PTSD, Hum. Psychopharmacol, vol.26, pp.4-11, 2011.

K. Ritchie, Prevalence of DSM-IV psychiatric disorder in the French elderly population, Br. J. Psychiatry, vol.184, pp.147-152, 2004.

. The-3c-study and . Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

M. F. Folstein, S. E. Folstein, and P. R. Mchugh, Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res, vol.12, pp.189-198, 1975.

R. H. Harwood, M. J. Prince, A. H. Mann, and S. Ebrahim, The prevalence of diagnoses, impairments, disabilities and handicaps in a population of elderly people living in a defined geographical area: the Gospel Oak project, Age. Ageing, vol.27, pp.707-714, 1998.

K. Ritchie, Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression, J. Clin. Psychiatry, vol.70, pp.1281-1288, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00325784

Y. Lecrubier, A short diagnostic structured interview: reliability and validity according to the CIDI, Eur. Psychiatry, vol.12, pp.224-231, 1997.

D. Sheehan, The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability, Eur. Psychiatry, vol.12, pp.232-241, 1997.

K. Ritchie, J. Norton, A. Mann, I. Carriere, and M. L. Ancelin, Late-onset agoraphobia: general population incidence and evidence for a clinical subtype, Am. J. Psychiatry, vol.170, pp.790-798, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00908016

, Diagnostic and statistical manual of mental disorders, 1994.

D. A. Clark, Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/ schizoaffective disorder in a Spanish isolate population, Biol. Psychiatry, vol.58, pp.435-439, 2005.

J. Elia, Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A, Psychiatr. Genet, vol.19, pp.134-141, 2009.

Y. R. Liu, ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics, Pharmacogenomics. J, vol.10, pp.30-39, 2010.

S. R. Freitas, A. C. Pereira, M. S. Floriano, J. G. Mill, and J. E. Krieger, Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population, BMC. Cardiovasc. Disord, vol.8, p.40, 2008.

J. Lochman, V. J. Balcar, F. Stastny, and O. Sery, Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes, Psychiatry. Res, vol.205, pp.7-12, 2013.

D. E. Comings, N. S. Gonzalez, S. C. Cheng-li, and J. Macmurray, A "line item" approach to the identification of genes involved in polygenic behavioral disorders: the adrenergic alpha2A (ADRA2A) gene, Am. J. Med. Genet. B. Neuropsychiatr. Genet, vol.118, pp.110-114, 2003.

N. Perroud, Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project, Neuropsychopharmacology, vol.34, pp.2517-2528, 2009.

S. Sober, Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array, PLoS One, vol.4, p.6034, 2009.

T. Jin, L. Liu, and . Minireview, The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus, Mol. Endocrinol, vol.22, pp.2383-2392, 2008.

A. Migliorini and H. Lickert, Beyond association: A functional role for Tcf7l2 in ? -cell development, Mol Metab, vol.4, pp.365-366, 2015.

C. Faisy, Wnt/beta-catenin signaling modulates human airway sensitization induced by beta2-adrenoceptor stimulation, PLoS One, vol.9, p.111350, 2014.

T. Hansen, At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia, Biol. Psychiatry, vol.70, pp.59-63, 2011.

J. C. Florez, TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program, N. Engl. J. Med, vol.355, pp.241-250, 2006.

A. H. Rosengren, Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes, Diabetes, vol.61, pp.1726-1733, 2012.

Z. Bochdanovits, A Functional polymorphism under positive evolutionary selection in ADRB2 is associated with human intelligence with opposite effects in the young and the elderly, Behav. Genet, vol.39, pp.15-23, 2009.

D. M. Lyall, ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936, Behav. Genet, vol.43, pp.13-23, 2013.

I. Liberzon, Interaction of the ADRB2 gene polymorphism with childhood trauma in predicting adult symptoms of posttraumatic stress disorder, JAMA Psychiatry, vol.71, pp.1174-1182, 2014.

D. Rosskopf and M. C. Michel, Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine, Pharmacol. Rev, vol.60, pp.513-535, 2008.

K. Cheslack-postava, beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort, Mol. Psychiatry, vol.12, pp.283-291, 2007.

B. Freeman, DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping, Behav. Genet, vol.33, pp.67-72, 2003.

M. L. Ancelin, Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression, Transl. Psychiatry, vol.3, p.322, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00914310

J. C. Lambert, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nat. Genet, vol.41, pp.1094-1099, 2009.

S. Rajagopal, K. Rajagopal, and R. J. Lefkowitz, Teaching old receptors new tricks: biasing seven-transmembrane receptors, Nat. Rev. Drug. Discov, vol.9, pp.373-386, 2010.

J. M. Kent, S. J. Mathew, and J. M. Gorman, Molecular targets in the treatment of anxiety, Biol. Psychiatry, vol.52, pp.1008-1030, 2002.

G. S. Wang and T. A. Cooper, Splicing in disease: disruption of the splicing code and the decoding machinery, Nat. Rev. Genet, vol.8, pp.749-761, 2007.

A. A. Litonjua, Very important pharmacogene summary ADRB2, Pharmacogenet. Genom, vol.20, pp.64-69, 2010.

A. Thakkinstian, Systematic review and meta-analysis of the association between ? 2-adrenoceptor polymorphisms and asthma: a HuGE review, Am. J. Epidemiol, vol.162, pp.201-211, 2005.

M. R. Taylor, Pharmacogenetics of the human beta-adrenergic receptors, Pharmacogenomics. J, vol.7, pp.29-37, 2007.

M. Ayalew, Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction, Mol. Psychiatry, vol.17, pp.887-905, 2012.

K. Huang, No association found between the promoter variants of ADRA1A and schizophrenia in the Chinese population, J. Psychiatr. Res, vol.42, pp.384-388, 2008.

L. F. Saliba, Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women, Genet. Mol. Biol, vol.37, pp.15-22, 2014.

D. Clark, I. Mata, R. Kerwin, J. Munro, and M. Arranz, No association between ADRA2A polymorphisms and schizophrenia, Am. J. Med. Genet. B. Neuropsychiatr. Genet, vol.144, pp.341-343, 2007.

I. Burcescu, Association study of the adrenergic receptors and childhood-onset mood disorders in Hungarian families, Am. J. Med. Genet. B. Neuropsychiatr. Genet, vol.141, pp.227-233, 2006.

K. Ohara, M. Nagai, K. Tani, T. Tsukamoto, and Y. Suzuki, Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders, Neuroreport, vol.9, pp.1291-1294, 1998.

D. E. Comings and J. P. Macmurray, Molecular heterosis: a review, Mol. Genet. Metab, vol.71, pp.19-31, 2000.

L. Joos, Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers, Thorax, vol.58, pp.703-707, 2003.

T. A. Durham, Posttraumatic stress disorders dysphoria dimension and relations with generalized anxiety disorder symptoms, Psychiatry. Res, vol.228, pp.150-155, 2015.